← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-5 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, AMVAC + Nivolumab)

Muscle-Invasive Bladder Carcinoma · Muscle-Invasive Bladder Carcinoma

#Muscle-InvasiveBladderCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
CGTBiologicstaleThe Catholic University of KoreaPhase 2

Ex vivo-expanded NK cell enriched lymphocytes (ANKL, ANKL(Ex vivo-expanded NK cell enriched lymphocytes))

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleAnocca ABPhase 2

TCR-T cells targeting KRAS G12V mutation presented by specific HLA alleles (ANOC-001, ANOC-001 (TCR-T cells targeting KRAS G12V mutation presented by specific HLA alleles))

PDAC · PDAC

#PDAC#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleAnocca ABPhase 2

TCR-T cells targeting KRAS G12V mutation presented by specific HLA alleles (ANOC-002, ANOC-002 (TCR-T cells targeting KRAS G12V mutation presented by specific HLA alleles))

PDAC · PDAC

#PDAC#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleAnocca ABPhase 2

TCR-T cells targeting KRAS G12D mutation presented by specific HLA alleles (ANOC-003, ANOC-003 (TCR-T cells targeting KRAS G12D mutation presented by specific HLA alleles))

PDAC · PDAC

#PDAC#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
AntibodystalePeking Union Medical CollegePhase 2

trastuzumab (Herceptin, AR,AR antagonist ++ goserelin + pertuzumab + trastuzumab)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

ARX788 + Cemiplimab (ARX788 + Cemiplimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
CGTBiologicstaleThe Affiliated Hospital of Xuzh…Phase 2

ASCT+CAR-T Cell Infusion (ASCT+CAR-T Cell Infusion)

B-cell Lymphoma · B-cell Lymphoma

#B-cellLymphoma#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
ADCBiologicstaleKirilys Therapeutics Inc.Phase 1

ASN004 (ASN004)

Solid Tumor · Solid Tumor

#SolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleAstellas Pharma Global Developm…Phase 2

ASP2998 (ASP2998)

Locally Advanced or Metastatic Malignant Solid Tumors · Locally Advanced or Metastatic Malignant

#LocallyAdvancedorMetastaticMalig#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleAxcynsis Therapeutics Pte LtdPhase 1

AT03-65 (AT03-65)

Solid Tumor · Solid Tumor

#SolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleAntengene Therapeutics LimitedPhase 1

nivolumab (Opdivo, ATG-017+Nivolumab)

Solid Tumor; Hematological Malignancy · Solid Tumor

#SolidTumor#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleUniversitair Ziekenhuis BrusselPhase 2

ATG-Rituximab-MMF-TAC (ATG-Rituximab-MMF-TAC)

Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 1

#DiabetesMellitusType1#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleUniversitair Ziekenhuis BrusselPhase 2

ATG-basilixumab-MMF-TAC (ATG-basilixumab-MMF-TAC)

Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 1

#DiabetesMellitusType1#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
CGTBiologicstaleUNC Lineberger Comprehensive Ca…Preclinical

ATLCAR.CD30 (ATLCAR.CD30)

Hodgkin Lymphoma, Adult · CD30

#CD30#CGT#Preclinical#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleUNC Lineberger Comprehensive Ca…Phase 1

ATLCAR.CD30.CCR4 cells (ATLCAR.CD30.CCR4 cells)

Lymphoma; Immune System Diseases · CD30

#CD30#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleAutolus LimitedPhase 2

AUTO CAR T cell therapy (AUTO CAR T cell therapy)

Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy; Multiple Myeloma · Patients Followed for up to 15 Years Fol

#PatientsFollowedforupto15YearsFo#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleAbbViePreclinical

Alvotech Biosimilar to Adalimumab (AVT02, AVT02 (Alvotech Biosimilar to Adalimumab))

Crohn Disease; Ulcerative Colitis · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
ADCBiologicstaleAstraZenecaPhase 2

AZD0516 (AZD0516)

Metastatic Prostate Cancer · Metastatic Prostate Cancer

#MetastaticProstateCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

AZD4360 (AZD4360)

Gastric Cancer; Gastroesophageal Junction Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING

74 / 177 페이지

← 이전다음 →